LITTLE GREEN PHARMA LTD — Director's Dealing 2026

Feb 25, 2026

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public. Introduced 30/9/2001.

Name of entity	Little Green Pharma Ltd
ACN	615 586 215

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Michael David Lynch-Bell
Date of last notice	22 July 2025

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Direct
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	N/A
Date of change	26 February 2026
No. of securities held prior to change	(a) 1,828,450 Ordinary shares (b) 140,000 Retention Share Rights vesting 20 Feb 26, expiring 20 Feb 28 (c) 300,000 Retention Share Rights vesting 31 Mar 27,expiring on 31 Mar 29
Class	(a) Ordinary shares (b) Retention Share Rights vesting 20 Feb 26, expiring 20 Feb 28
Number acquired	(a) 140,000 Ordinary shares
Number disposed	(b) 140,000 Retention Share Rights vesting 20 Feb 26, expiring 20 Feb 28
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	Nil - shares issued on exercise of vested retention share rights

• See chapter 19 for defined terms.

Appendix 3Y Page 1

11/3/2002

Appendix 3Y Change of Director’s Interest Notice

No. of securities held after (a) 1,968,450 Ordinary shares change (b) Nil (c) 300,000 Retention Share Rights vesting 31 Mar 27,expiring on 31 Mar 29 Nature of change Exercise of vested retention share rights Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Note: In the case of a company, interests which come within	paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this
Detail of contract	N/A
Nature of interest
Name of registered holder (if issued securities)
**Date of change **
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which theinterest has changed
Interest acquired
Interest disposed
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation
Interest after change

Part 3 – +Closed period

Interest after change Part 3 – +Closed period
Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required?	No
If so, was prior written clearance provided to allow the trade to proceed during this period?	N/A
If prior written clearance was provided, on what date was this provided?	N/A

• See chapter 19 for defined terms.

Appendix 3Y Page 2

11/3/2002

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public. Introduced 30/9/2001.

Name of entity	Little Green Pharma Ltd
ACN	615 586 215

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Neale William Fong
Date of last notice	22 July 2025

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Indirect
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	Riverpalm Pty Ltd ATF NW Fong Family Trust -Dr Fong is a director and beneficiary of the trust Dr Neale Fong ATF Damblock Trust -Dr Fong is a trustee and beneficiary of the trust
Date of change	26 February 2026
No. of securities held prior to change	Riverpalm Pty Ltd (a) 296,154 Ordinary shares Dr Neale Fong (a) 1,289,575 Ordinary shares (b) 70,000 Retention Share Rights vesting 20 Feb 26, expiring 20 Feb 28 (c) 150,000 Retention Share Rights vesting 31 Mar 27, expiring 31 Mar 29
Class	(a) Ordinary shares (b) Retention Share Rights vesting 20 Feb 26, expiring 20 Feb 28
Number acquired	(a) 70,000 Ordinary shares
Number disposed	(b) 70,000 Retention Share Rights vesting 20 Feb 26, expiring 20 Feb 28

• See chapter 19 for defined terms.

Appendix 3Y Page 1

11/3/2002

Appendix 3Y Change of Director’s Interest Notice

Value/Consideration Nil - shares issued on exercise of vested retention share rights Note: If consideration is non-cash, provide details and estimated valuation No. of securities held after Riverpalm Pty Ltd change (a) 296,154 Ordinary shares Dr Neale Fong (a) 1,359,575 Ordinary shares (b) Nil (c) 150,000 Retention Share Rights vesting 31 Mar 27, expiring 31 Mar 29 Nature of change Exercise of vested retention share rights Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Note: In the case of a company, interests which come within	paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this
Detail of contract	N/A
Nature of interest
Name of registered holder (if issued securities)
**Date of change **
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which theinterest has changed
Interest acquired
Interest disposed
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation
Interest after change

Part 3 – +Closed period

Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required?	No
If so, was prior written clearance provided to allow the trade to proceed during this period?	N/A
If prior written clearance was provided, on what date was this provided?	N/A

• See chapter 19 for defined terms.

Appendix 3Y Page 2

11/3/2002